Non-setting, injectable biomaterials containing particulate hydroxyapatite can increase primary stability of bone screws in cancellous bone by Solana Muñoz, Jorge et al.
Contents lists available at ScienceDirect
Clinical Biomechanics
journal homepage: www.elsevier.com/locate/clinbiomech
Non-setting, injectable biomaterials containing particulate hydroxyapatite
can increase primary stability of bone screws in cancellous bone
Jorge Solana Muñoza, Ulrike Kettenbergera, Philip Procterb, Dominique P. Piolettia,⁎
a Laboratory of Biomechanical Orthopedics, Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne (EPFL), Switzerland
bApplied Materials Science, Department of Engineering Sciences, Uppsala University, Sweden
A R T I C L E I N F O
Keywords:
Weak bone quality
Screw augmentation
Soft material
Hydrogel
Primary stability
Osteoporosis
A B S T R A C T
Background: Fracture ﬁxation in weak bone is still a clinical challenge. Screw augmentation was shown to
successfully increase their primary stability. The currently used calcium phosphate or polymeric bone cements,
however, present important drawbacks such as induced toxicity and/or impaired bone neo-formation. A new
approach to enhance bone screw primary stability without aﬀecting bone formation is the use of non-setting,
calcium phosphate loaded soft materials as the augmentation material.
Methods: Two types of biomaterials (non-crosslinked hyaluronic acid as viscous ﬂuid and agar as hydrogel) were
loaded with 40 wt/vol% of hydroxyapatite particles and characterized. The screw augmentation eﬀect of all
materials was evaluated through pull-out tests in bovine cancellous bone and compared to the non-augmented
situation (control). The bone mineral density of each test sample was measured with μCT scans and was used to
normalize the pull-out strength.
Findings: Both materials loaded with hydroxyapatite increased the normalized pull-out strength of the screws
compared to control samples and particle-free materials. This counter-intuitive augmentation eﬀect increased
with decreasing bone mineral density and was independent from the type of the soft materials used.
Interpretation: We were able to demonstrate that non-setting, injectable biomaterials loaded with ceramic par-
ticles can signiﬁcantly enhance the primary stability of bone screws. This material combination opens the unique
possibility to achieve a screw augmentation eﬀect without impairing or even potentially favoring the bone
formation in proximity to the screw. This eﬀect would be particularly advantageous for the treatment of os-
teoporotic bone fractures requiring a stabilization with bone screws.
1. Introduction
Osteoporosis related fractures in the elderly population are an in-
creasing burden on healthcare systems (Johnell and Kanis, 2006). Hip
fracture is by far the most common reason for hospital admission, it
may occurs either as a result of a fragility fracture (Acevedo et al.,
2018) or a fall. Most hip fracture patients receive operative treatment
(Weycker et al., 2016; Williamson et al., 2017). The ability of the
proximal femur to bear the internal load actions resulting from a fall is
signiﬁcantly reduced by osteoporosis and in particular, it has been
demonstrated that this is related to reduced areal bone mineral density
(Curtis et al., 2016).
Each form of treatment following a bone fracture may result in
undesired outcomes or complications. For example, in the use of screws
to ﬁxate undisplaced femoral neck fractures, the holding power of the
screw may be limited by the degree of osteoporosis reduction in bone
density in the regions where the surgeon tries to obtain purchase
(Konstantinidis et al., 2016). Poor screw purchase may result in screw
loosening and/or migration during the healing period and may ne-
cessitate a further operative intervention which is undesirable in elderly
patients (Do et al., 2016; Rogmark et al., 2009). Diﬀering clinical opi-
nions on how to deal with this particular complication has led some
surgeons to advocate going directly to an endoprosthesis or total hip
replacement, whilst others have considered changing the design of the
implant and/or modifying the surgical technique (Gardner et al., 2004).
In this latter group, the use of cements to augment the ﬁxation of the
screw in the bone has been considered. This strategy has been the
subject of many preclinical animal studies in which both poly methyl
methacrylate (PMMA) and calcium phosphate (CaP) based injectable
cements have been proposed as solutions (Stankewich et al., 1996;
Stoﬀel et al., 2008; von der Linden et al., 2006). The purpose of cement
augmentation is to improve the holding power of the screw and reduce
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the risk of migration during the fracture healing phase. Whilst there is
good biomechanical support for this concept in ex vivo and in vivo
preclinical models, however, in patients there is very little evidence
that clinical outcomes are positively inﬂuenced. In intra capsular fe-
moral neck fractures, there are also very few prospective randomized
studies on cement augmentation. Mattsson and Larsson (2003) showed
improved stability of internally ﬁxed femoral neck fractures at one
week and less pronounced at six weeks after surgery. The same authors
later concluded that CaP cement augmentation did not improve results
after internal ﬁxation of displaced femoral neck fractures in a rando-
mized study of 118 patients (Mattsson and Larsson, 2006). The same
group also reported that in particular the use of injectable CaP resulted
in impaired blood supply in femoral neck fractures (Mattsson et al.,
2005).
Several alternative strategies have then been proposed to augment
ﬁxation of screws in poor quality cancellous bone (Parker and Handoll,
2009). The use of hydroxyapatite (HaP) coatings has been suggested by
a number of authors, and Moroni in particular claims it was beneﬁcial
when hip screws were coated and used in ﬁxing hip fractures (Moroni
et al., 2004). The number of patients however was insuﬃcient to justify
such a conclusion. An Italian group looked at HaP coated implants long
term using Dexa to assess the local bone formation and concluded that
there was a signiﬁcant increase in local bone density (Pesce et al.,
2014). Alternatively, the local delivery of bone modifying drugs has
also been considered. The use of Zoledronic (Zol) acid for example
through a screw surface has shown to be feasible and beneﬁcial in both
pre-clinical (Greiner et al., 2008; Kettenberger et al., 2015; Peter et al.,
2006) and clinical studies (Abtahi et al., 2012). Whilst this has not lead
to any signiﬁcant use outside of experimental studies, a dental implant
pilot study has reached 5-year follow-up in patients showing less bone
resorption close to the Zol delivering implants (Abtahi et al., 2016). For
the coatings mentioned above, the eﬀects are observed at mid to long
term and neither is able to assure primary stability at the time of sur-
gical intervention.
The present study hypothesis was formulated based on an earlier
study in which Zol was delivered from hydroxyapatite particles em-
bedded in a hydrogel matrix into peri-implant bone in a rat femoral
model (Kettenberger et al., 2015). In this study, the control group of
hydrogel loaded only with hydroxyapatite particles showed an un-
expected mineralization of the hydrogel that led to an in situ formation
of an osteoconductive scaﬀold. This high biological activity of the
material with an induction of the body's own mineralization processes
and an integration of the forming mineralized granules into viable bone
makes this material combination highly attractive for bone augmenta-
tion. On the long term, this material seems to overcome the inherent
limitations of bone cement such as the not existing or very slow re-
sorption, the risk of leakage into articulations, and a potential impair-
ment of the blood supply leading to an avascular necrosis of certain
bone regions. It appears that the only major disadvantage of a hydro-
xyapatite-loaded hydrogel is its soft, non-setting consistency that is not
expected to improve the primary stability of implants.
If it can be shown that the material combines both mechanical and
biological performance and an improvement of the primary implant
stability can be obtained, then this would potentially be of great clinical
interest. Accordingly, the hypothesis in the present study is that the
addition of an increased particulate percentage to soft biomaterials can
signiﬁcantly enhance the primary stability of bone screws in cancellous
bone, whilst still remaining injectable.
2. Methods
2.1. Design of the study
Bovine distal femurs were used as sources of cancellous bone sam-
ples, which were prepared in the form of cylindrical cores of 20 mm of
diameter and 20 to 25mm of length. A titanium cancellous bone screw
(ref: 604026, Cancellous Screw, Stryker, Selzach, Switzerland) was in-
serted into a predrilled hole that was coincident with the axis of each
cylindrical bone sample. The mechanical inﬂuence of diﬀerent bioma-
terials on cancellous bone screw stability was tested. The method used
to compare the mechanical properties of those biomaterials was to in-
ject each material into the screw hole prior to screw insertion and
subsequent pull-out testing. The data from the pull-out testing and a
micro-computerized tomography (μCT) analysis of the trabecular bone
density were used to interpret the eﬀect of the tested biomaterials.
2.2. Biomaterial preparation
The study included 5 experimental groups, 4 groups for which the
predrilled screw-holes were ﬁlled with a biomaterial and one group for
which the holes were left empty (Control). The biomaterials were the
following: the hydrogel agar with a concentration of 2 wt/vol% pure
(Agar) or loaded with 40 wt/vol% of HaP (AgarHaP) and the viscous
ﬂuid hyaluronic acid with a concentration of 3.5 wt/vol% pure
(Hyalectine) or loaded with 40 wt/vol% of HaP (HyalectineHaP). All
products are commercially available (hydroxyapatite particles: ref
04238, hydroxyapatite, Sigma-Aldrich, Buchs, Switzerland; agar: ref
05039, AgarAgar, Sigma-Aldrich, Buchs, Switzerland; hyaluronic acid:
Hyalectine, 800 kD, Fidia farmaceutici, Italy).
The preparation of the hydrogel used for the group Agar started by
dissolving 2 wt/vol% of agar in phosphate buﬀered saline (PBS, pre-
pared in-house, pH 7.4) at room temperature (RT). Subsequently the
solution was heated above 90 °C to activate the agar and afterwards
cooled down to RT. For the AgarHaP group, 40 wt/vol% of HaP were
additionally added to the agar solution prior to the heating step.
For the Hyalectine group, a non-crosslinked hyaluronic acid was
used as injectable biomaterial. For its preparation, 3.5 wt/vol% of
Hyalectine powder was dissolved in PBS under continuous stirring with
a laboratory spatula. For the HylectineHaP group, 40 wt/vol% of HaP
were added to the Hyalectine powder previously to the dissolution in
PBS.
The 4 biomaterials were ﬁlled into labelled syringes and stored at
4 °C until use.
2.3. Bone sample preparation
The bovine bones were obtained from a local slaughterhouse at the
day of animal slaughter. To get the 5 experimental groups, about 120
bovine samples were extracted from 13 adult bovine distal femurs
(condyles and trochlea, position of the extraction site shown in Fig. 1).
Those samples were sorted following the validation criteria explained
below. At the end, 63 bone samples were found to be usable, giving a
number between 11 and 15 samples per experimental group. As ﬁrst
preparation step, all soft tissues around the bovine distal femurs were
removed before placing the samples at −20 °C in the freezer. In a
second step, the bone cylinders were extracted using a crown drill
mounted in a column drill machine (Bosch PBD 40, Leinfelden-Ech-
terdingen, Germany), turning at 200 rpm and a band saw (Rexon BS-
12RA, Taichung, Taiwan) at its slowest speed. The extracted samples
were cylinder-shaped with a diameter of 20mm and a length of
not< 20mm. The cortical layer was retained and the surface of the
cortical bone was cleaned from remaining soft tissue to reduce the
variance in drilling and screw insertion depth. Immediately after ex-
traction, the samples were placed individually in laboratory tubes
(Falcon™ Conical Centrifuge Tube, 50ml, Corning Life Sciences B.V.,
Amsterdam, The Netherlands) and kept in the freezer at −20 °C until
further processing.
2.4. Bone sample characterization and selection
Micro-computerized tomography scans (μCT) (Skyscan 1076,
Bruker microCT, Kontich, Belgium) of all samples were performed to
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examine the bone quality before drilling the screw holes. The images
were obtained using the following parameters: 1 mm aluminium ﬁlter,
voltage 100 kV, current 100 μA, exposure time 120ms, rotation step
0.5°, angle coverage 180° and spatial resolution 35 μm. A calibration of
the attenuation coeﬃcient versus bone mineral density (BMD in g/cm3)
was done for every session by scanning two cylindrical polymer-hy-
droxyapatite phantoms with a diameter of 16mm and known mineral
density under the same conditions than the bone samples. Image re-
construction was done with the software NRecon and GPURecon Server
(Bruker microCT, Kontich, Belgium). The trabecular BMD values were
obtained from a cylindrical region of about 8mm of diameter and
15mm of length at the centre of every bone sample located below the
cortical shell (Fig. 2). This cylindrical region was deﬁned large enough
to include the bone region in which the cancellous screw (diameter
4mm) was anchored later on.
Three main aspects were analysed: the cancellous BMD, the cortical
shell thickness, and the bone structure around the screw position. The
BMD is generally used as part of the diagnosis protocol for osteopenia
and osteoporosis (Cosman et al., 2014) and was correspondingly used
as a normalization factor in this study. Every sample with a cortical
shell thicker than 1.5mm was rejected as, based on a previous study
(Seebeck et al., 2005), it was demonstrated in human cadaver tibial
bone that the pull-out strength is dominated by the cortical shell for a
shell thicker than 1.5 mm. Finally, a visual analysis of the reconstructed
samples was used to exclude samples with atypical trabecular bone
structure and samples that included part of the growth plate. To prevent
the bone samples from drying, those were wrapped with standard la-
boratory plastic ﬁlm (Paraﬁlm M, Sigma-Aldrich, Steinheim, Germany)
during the full scanning process and immediately placed back in the
freezer at −20 °C after the scan. During the scan, the frozen samples
were exposed to room temperature and hence thawing for approxi-
mately 12min.
2.5. Augmentation technique
A similar procedure was followed for all the tested groups. In a ﬁrst
step, the samples were thawed inside the tubes by placing the tubes into
a water bath with a temperature between 37 °C and 40 °C. Then the
column drill machine was used to drill holes with a diameter of 2.5 mm
and a depth of 18mm, measured from the cortical surface, into the
specimens with a standard drill bit. A 90° angle between the drilling
axis and the cortical surface was targeted. The screw hole depth was
measured with the digital depth sensor of the drilling machine. Apart
from the control group, between 0.1ml and 0.3ml of the diﬀerent
biomaterials (see Table 1) were injected into the screw holes with a
positive displacement pipette (Distriman® with Distritip® 1,25ml,
Fig. 1. Locations of bone sample extraction on bovine knee.
Fig. 2. Reconstructed microCT scan of a bovine bone sample showing in red the volume for which the trabecular BMD was computed. This cylindrical volume with a
diameter of 8mm and a height of 15mm is located 1.5 mm below the cortical surface. (For interpretation of the references to color in this ﬁgure legend, the reader is
referred to the web version of this article.)
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Gilson, Middleton, USA) until an overﬂow was observed. The outlet
diameter of this pipette tip is approximately 0.5mm corresponding to
the inner diameter of a 21G cannula. Commercially available ortho-
paedic cancellous bone screws with a length of 26mm and a diameter
of 4mm (ref: 604026, Cancellous Screw, Stryker, Selzach, Switzerland)
were manually inserted to a depth of 18mm directly after biomaterial
application. The correct insertion depth was controlled with a calliper.
The measured screw head protrusion was 8 ± 0.1mm.
2.6. Mechanical pull-out tests procedure
Before performing the pull-out test, the samples were ﬁxed with a
fast curing resin (Technovit 3040, Wehrheim, Germany) as proposed in
earlier publications (Rincón-Kohli et al., 2009), into a specially de-
signed mould that served equally as sample holder for the pull-out test.
The mechanical tensile strength was applied by a tensile actuator (ref:
E3000KZ832, Instron 3000, High Wycombe, England) at a rate of
5mm/min, between the bone sample holder and the screw head holder.
The data were acquired with an axial strength transducer (ref: 66901,
Dynacell Dynamic Load Cell 5 kN, Instron) and automatically saved in
an excel ﬁle. The pull-out strength was deﬁned as the maximum tensile
strength at the moment of bone failure (Fig. 3). The obtained pull-out
strengths were normalized with the corresponding BMD of each bone
sample. Linear curves were ﬁtted to the results of each group to obtain
the pull-out strength as function of the BMD. The relative diﬀerences in
% between the resulting functions of the test groups and the function of
the control group as reference were computed to obtain the augmen-
tation eﬀect of each tested biomaterial in relation to the BMD.
2.7. Statistical analysis
The software Matlab (MathWorks, Natick, United States) was used
for the statistical analysis of the results. A one-way ANOVA test fol-
lowed by a multi-comparison test (Tuckey's honest signiﬁcant diﬀer-
ence criterion) was used to compare means of normalized pull-out
strength between the diﬀerent tested groups. A p value equal or lower
than 0.05 was considered as signiﬁcative.
3. Results
3.1. Characterization of the bone samples
The mean BMD and corresponding standard deviation for each
group are reported in Table 2. No signiﬁcant diﬀerences were observed
between the BMD of the ﬁve experimental groups.
3.2. Mechanical pull-out tests
The normalized pull-out strengths of the ﬁve experimental groups
are shown in Fig. 4. No signiﬁcant diﬀerences were observed between
the Control, the Hyalectine and the Agar groups indicating that a pure
soft material does not have an eﬀect on the primary stability of can-
cellous bone screws. However, signiﬁcant diﬀerences were found be-
tween the two particle-loaded groups HyalectineHaP (p < 0.0005) and
AgarHaP (p < 0.001) and the Control. The results show an augmen-
tation eﬀect in the mean values of normalized pull-out strength of 27%
for the group AgarHaP and 33% for HyalectineHaP when compared to
the Control, which was 4481.4 N cm3/g.
The computed augmentation eﬀects of the AgarHaP and the
HyalectineHaP group in relation to the BMD are shown in Fig. 5. The
data show that the augmentation eﬀect is strongest for a low BMD and
decreases with increasing BMD values.
4. Discussion
To our knowledge, we were the ﬁrst to hypothesize that a non-
setting soft material loaded with a suﬃcient amount of hydroxyapatite
particles can improve the primary stability of cancellous bone screws.
In this study, it was possible to conﬁrm this hypothesis via a standard
screw pull-out test with bovine cancellous bone samples. Two types of
soft biomaterials, agar as hydrogel and hyaluronic acid as viscous ﬂuid,
were used pure or loaded with 40 wt/vol% of HaP to ﬁll the pre-drilled
holes before screw insertion. Unﬁlled holes served as control. The re-
sults showed that the pure materials did not have any eﬀect on the
primary stability of the screws, the HaP loaded materials, however,
signiﬁcantly increased the pull-out strength. This augmentation eﬀect
was independent from the type of soft material used and increased with
decreasing BMD.
At ﬁrst glance, this positive eﬀect of HaP loaded biomaterials on
implant primary stability seems to be counter-intuitive as it is not ex-
pected that a non-setting, rather soft material can inﬂuence the pull-out
strength. However, when looking at the literature, this ﬁnding is still
aligned with earlier published discoveries. Steeves et al. found that the
pull-out strength of cancellous bone screws increases with decreasing
pilot hole diameter and explained this augmentation eﬀect through the
Table 1
The ﬁve tested groups with the hydrogels composition.
Group Agar Hyalectine HaP Samples number
Agar 2% – – 11
AgarHaP 2% – 40% 13
Hyalectine – 3.5% – 12
HyalectineHaP – 3.5% 40% 12
Control – – – 15
Fig. 3. a) Bone sample with an inserted screw; b) sample in the pull-out set-up;
c) example of a typical pull-out test result. The pull-out strength was measured
at the maximum of the curve (dotted line).
Table 2
Bovine mean and standard deviation (STD) of BMD (g/cm3) for each tested
group.
Group BMD
Mean STD Range
Agar 0.19 0.06 0.10 to 0.29
AgarHaP 0.20 0.09 0.09 to 0.35
Hyalectine 0.18 0.07 0.07 to 0.31
HyalectineHaP 0.21 0.08 0.11 to 0.33
Control 0.21 0.07 0.09 to 0.35
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ﬁlling of the space between trabeculae with loose bone debris (Steeves
et al., 2005). This eﬀect was also described earlier by Öktenoǧlu et al.
(2001). As the HaP loaded materials of the here presented study are also
pushed and compacted into the inter-trabecular space during the screw
insertion, an accumulation of the hydroxyapatite between the trabe-
culae could be expected and cause the observed augmentation eﬀect.
Tami et al. applied hydroxyapatite particles alone in the pre-drilled
screw holes in the proximal tibial metaphysis of OVX rats (Tami et al.,
2009). Pull-out tests, histology, and microCT showed that the particles
induced a stronger peri-implant bone mantle that improved the pull-out
strength of the screws on the long term. However, no inﬂuence of the
HaP on the primary stability of the screws was observed. This might be
explained by the very small implant size in the rat model and the
limited amount of HaP that could be applied to the pilot hole.
The challenge of obtaining adequate primary ﬁxation of osteo-
porotic fractures has lead researchers and clinicians to consider the use
of cements to augment ﬁxation screws. Whilst the preclinical literature
is broadly supportive of both calcium and PMMA based cements there
is, so far, a lack of clinical support for the hoped-for beneﬁts in hip
fracture ﬁxation. Accordingly, the results of the present study must be
treated with caution until both the eﬀectiveness and the biological
safety have been validated in an appropriate preclinical animal model.
It should be mentioned that the future clinical use of calcium-based
cement in combination with screws to augment ﬁxation of fractured
neck of femur should probably be limited to the undisplaced grades
where the risk of avascular necrosis is known to be less (Popelka et al.,
2015).
The originality of the present study is to combine HaP and a soft,
non-setting biomaterial. The aqueous, soft matrix makes the material
injectable through a small needle and would signiﬁcantly facilitate the
application in clinics. Depending on the type of biomaterial used, the
matrix itself can have further beneﬁts. Hyaluronic acid, for example, is
known to support healing processes and to be bacteriostatic and anti-
inﬂammatory (Carlson et al., 2004; Dahiya and Kamal, 2013).
The combination between hydroxyapatite and hyaluronic acid has
also been shown to induce a rapid in vivo mineralization leading to the
in situ formation of an osteoconductive scaﬀold when applied into poor
quality, peri-implant bone (Kettenberger et al., 2015). However, it has
to be noted that this study was performed with a much lower HaP
content than the present study. A similar positive biological eﬀect with
a HaP content of 40 wt/vol% in soft materials remains to be veriﬁed in
an in vivo study.
There are some inherent limitations in the present study. First, the
two soft materials used for this study, agar and non-crosslinked hya-
luronic acid, only served as model substances and were chosen because
of their simple preparation and handling. Agar is a hydrogel with a 3-
Fig. 4. Comparison of normalized pull-out strength for the ﬁve tested groups. In each box, the internal line indicates the median, the box designates the interquartile
range and the whiskers point out the extreme data points. The star ‘*’ and the speciﬁed p-values identify the groups with signiﬁcant diﬀerence with the group Control.
Fig. 5. Visualization of the augmentation eﬀect of the AgarHaP and the HyalectineHaP group. The augmentation eﬀect was deﬁned as the increase in BMD
normalized pull-out strength compared to the Control group, within the assumption of linear correlation between pull-out strength and BMD.
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dimensional molecular network that is crushed into pieces when it is
deformed, for example during injection. Non-crosslinked hyaluronic
acid, in contrast, is a viscous ﬂuid which is freely deformable due to a
lacking polymer chain network. Non-crosslinked hyaluronic acid is
characterized by a very high turnover in the human body and would be
resorbed in vivo within several days (Stern, 2004). For an in vivo ap-
plication, it is debatable if a non-cross-linked, quickly resorbable ma-
terial is suﬃcient as transport medium for the hydroxyapatite particles
or if a longer persisting, cross-linked matrix would be needed. It is
unclear, if and how a rapid disappearance of the matrix inﬂuences the
implant stability and the biological response over time. The presented
experiments can only capture the situation immediately after screw
insertion and animal tests would be needed for an evaluation of the
temporal development of the implant integration and stability.
Another limitation of the presented study is the bovine origin of the
bone. It is well known that the BMD of bovine bone is generally higher
than the human ones. To partially circumvent this limitation, only the
lowest BMD values of the bovine bone samples used for this study
(mean BMD: 0.2021 g/cm3) were within the range of values obtained
from human femurs (neck mean BMD: 0.0888 g/cm3, head mean BMD
0.1273 g/cm3) reported in a recent study (Maeda et al., 2011). To de-
crease the importance of the BMD in the pull-out test, a normalization
of the obtained pull-out strength by the BMD was proposed in the
present study. From the mechanical point of view, whilst it is evident
that there are diﬀerences in bone properties between human and the
range of animal models in current use (Aerssens et al., 1998), there is
some support for comparable properties (An, 1999). It has been de-
monstrated that there is reasonable equivalence between compressive
strength and modulus of calf and human femoral neck bone (Ciarallo
et al., 2006). Additionally, a study (Fletcher et al., 2018) concludes that
juvenile bovine is a reasonable surrogate for human bone in screw
pullout testing.
The conservation methods could have inﬂuenced the mechanical
properties of the bone sample. Indeed, the bone samples were subjected
to only one thaw-freeze cycle, which is typical to most biomechanical
studies. Moreover, as all samples were processed in a similar way, even
if a bias would have been induced by the conservation method, relative
comparison of the mechanical tests between samples would have can-
celled this bias. Due to technical problems during the experiments,
some samples had to be withdrawn from the study leading to an uneven
sample size between the groups. Finally for the limitation aspects of this
study, the insertion of the screw may produce particulate bone that may
tend to increase the insertion torque and consequently the pullout force
(Ab-Lazid et al., 2014). However it is an assumption that this eﬀect
would be similar for both test and control groups and so the diﬀerences
reported in Fig. 5 reﬂect the calcium particulate content.
The already observed biological advantages of HaP-loaded hydro-
gels and the augmentation eﬀect on the primary stability of bone screws
shown in this study make this composite biomaterial highly promising
for fracture ﬁxation in osteopenic or even osteoporotic bone. This
material could overcome the biological limitations of current aug-
mentation materials such as poor resorbability or possibly the risk of
avascular necrosis with no or only little loss in the mechanical stabili-
zation eﬀect. The good injection properties of the proposed material
makes it also suitable for minimal invasive application techniques.
Further research, especially with suitable in vivo models, will be ne-
cessary to conﬁrm the anticipated potential of this biomaterial.
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